Activated C3, Human, mAb I3/15 - HM2257-20UG

Quantity
20 µg
Catalog #
HM2257-20UG
125,00 €
C3 itself is a pivotal 190 kD protein central to the complement system, integral to the classical, alternative, and lectin pathways of complement activation. Notably, its synthesis is tissue-specific and responds dynamically to various stimulatory agents. Being the most abundant complement system protein, with serum levels around 1.3 mg/ml, C3's activation is a key event in immune response. Activation of C3, a critical step identified by the activated C3 antibody, involves its cleavage into C3a and C3b. C3a plays a vital role in mediating local inflammatory processes, with notable anaphylatoxic properties. It induces smooth muscle contraction, increases vascular permeability, and triggers histamine release from mast cells and basophils. Conversely, C3b attaches to immune complexes and undergoes further cleavage into iC3b, C3c, C3dg, and C3f. Collectively, these fragments are known as activated C3 (act. C3). The most significant function of these C3 fragments is their interaction with other immune cells. The neo-epitopes formed during activation, which the activated C3 antibody detects, are vital for understanding the complement cascade's impact on the immune system. Monoclonal antibodies like I3/15, which target these neo-epitopes, have become essential tools for directly quantifying activation at different steps of the complement cascade. Studying the activated C3 antibody's role in C3 activation is key for immune response insights and therapies. Not sure which C3 antibody to use? With numerous options available, it is essential to select the right C3 antibody to ensure the success of your research. We designed a guide to assist you in making an informed decision: Go to our C3 researcher's guide and choose the right antibody
Weitere Informationen
Datasheet URL https://www.hycultbiotech.com/wp-content/uploads/2023/05/SDS-HM2257-20UG.pdf
Quantity 20 µg
Quantity 20 µg
Species Human
Alias C3, PZP-like alpha-2-macroglobulin domain-containing protein 1
Application Immuno assays, Western blot
Precautions For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result from the use or derivation of this product.
References 1. Oppermann, M et al; Quantitation of components of the alternative pathway of complement (APC) by enzyme-linked immunosorbent assays. J Immunol Methods 1990: 133, 181
2. Oppermann, M et al; Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure. Kidney Int 1991: 40, 939
3. Würzner, R et al; Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP). Eur J Clin Invest 1991: 21, 288
4. Schuff-Werner, P et al; Heparin-induced extracorporeal LDL precipitation (HELP): rheological, hemostaseological and immunological effects. In Gotto, A et al; Treatment of severe hypercholesterolemia in the prevention of coronary heart disease, Basel, Karger 1990, 196
5. Zwirner, J et al; A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes. J of Immunol Meth 1995, 186, 55
Disease Infectious diseases, Nephrology
Applications
Application: Immuno assays Western blot

Newsletter
abonnieren

15% Rabatt

erhalten

Suchmaschine unterstützt von ElasticSuite